Filtros de búsqueda

Lista de obras de

Abicipar pegol: the non-monoclonal antibody anti-VEGF

scientific article published on 30 September 2019

Brolucizimab-leading an era of structural revolution for long-term VEGF suppression

scientific article published on 19 September 2019

Brolucizumab and fluid in neovascular age-related macular degeneration (n-AMD)

scientific article published on 04 March 2020

Brolucizumab and immunogenicity

scientific article published on 06 April 2020

Brolucizumab-another anti-VEGF or beyond

artículo científico publicado en 2020

Brolucizumab-early real-world experience: BREW study

scientific article published on 24 July 2020

Brolucizumab-key learnings from HAWK and HARRIER

artículo científico publicado en 2020

Brolucizumab-related retinal vasculitis: emerging disconnect between clinical trials and real world

artículo científico publicado en 2020

Brolucizumab: is extended VEGF suppression on the horizon?

artículo científico publicado en 2019

Brolucizumab: the road ahead

artículo científico publicado en 2020

Comment on: 'Recent advances in anterior chamber angle imaging'

artículo científico publicado en 2020

Correction: Brolucizumab-early real-world experience: BREW study

scientific article published on 15 December 2020

Correction: Comment on: 'Recent advances in anterior chamber angle imaging'

artículo científico publicado en 2020

Correction: MII RetCam assisted smartphone-based fundus imaging (MSFI)-a boon for paediatric retinal imaging

artículo científico publicado en 2020

Faricimab: expanding horizon beyond VEGF

scientific article published on 06 November 2019

Fluid-based prognostication in n-AMD: Type 3 macular neovascularisation needs an analysis in isolation

scientific article published on 08 December 2020

Immunogenicity and efficacy after switching from original Ranibizumab to a Ranibizumab biosimilar: real-world data

scientific article published on 16 December 2019

MII RetCam assisted smartphone-based fundus imaging (MSFI)-A boon for paediatric retinal imaging

scientific article published on 27 February 2020

Need of education on biosimilars amongst ophthalmologists: combating the nocebo effect

scientific article published on 29 November 2019

Notion of tolerating subretinal fluid in neovascular AMD: understanding the fine prints before the injection pause

artículo científico publicado en 2020

Ophthalmic biosimilars and biologics-role of endotoxins

scientific article published on 16 October 2019

Pachydrusen: the epidemiology of pachydrusen and its relevance to progression of pachychoroid disease spectrum

artículo científico publicado en 2020

Smartphone based ROP (S-ROP) screening-opportunities and challenges

artículo científico publicado en 2020

Understanding biosimilars and its regulatory aspects across the globe: an ophthalmology perspective

scientific article published on 17 July 2019

Dominio Público Uruguay está sostenido por:

Acerca de Dominio Público Uruguay

Ayuda